160 related articles for article (PubMed ID: 12420484)
1. Platelet-derived growth factor for foot ulcerations. An effective adjunct to good wound care.
Watts SA
Adv Nurse Pract; 2001 Sep; 9(9):60-3. PubMed ID: 12420484
[No Abstract] [Full Text] [Related]
2. [News in the management of chronic neuropathic diabetic ulcer].
Meaume S
Soins; 2001 Jun; (656):12-3. PubMed ID: 12008527
[No Abstract] [Full Text] [Related]
3. Preventing amputation in older adults with diabetes.
Umeh L
Adv Nurse Pract; 2006 Jul; 14(7):41-3, 70. PubMed ID: 16977896
[No Abstract] [Full Text] [Related]
4. Saving life and limb. Reducing amputations through good foot care.
Baer LH
Adv Nurse Pract; 2003 Nov; 11(11):70-2. PubMed ID: 14639886
[No Abstract] [Full Text] [Related]
5. Maggots 'n' chips: a novel approach to the treatment of diabetic ulcers.
Lodge A; Jones M; Thomas S
Br J Community Nurs; 2006 Dec; 11(12):suppl 23-6. PubMed ID: 17299900
[No Abstract] [Full Text] [Related]
6. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers.
Margolis DJ; Bartus C; Hoffstad O; Malay S; Berlin JA
Wound Repair Regen; 2005; 13(6):531-6. PubMed ID: 16283867
[TBL] [Abstract][Full Text] [Related]
7. Comparing the standard surgical dressing with dehydrated amnion and platelet-derived growth factor dressings in the healing rate of diabetic foot ulcer: A randomized clinical trial.
Mohammadi Tofigh A; Tajik M
Diabetes Res Clin Pract; 2022 Mar; 185():109775. PubMed ID: 35149167
[TBL] [Abstract][Full Text] [Related]
8. [Foot ulcers in the diabetic patient].
Richard JL
Soins; 2008; (722):42-5. PubMed ID: 18333346
[No Abstract] [Full Text] [Related]
9. Healing and preventing the diabetic foot wound: where technology, economics and common sense converge.
Armstrong DG
Indian J Med Sci; 2007 Jun; 61(6):324-5. PubMed ID: 17558094
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness of becaplermin gel on wound healing of diabetic foot ulcers.
Gilligan AM; Waycaster CR; Motley TA
Wound Repair Regen; 2015; 23(3):353-60. PubMed ID: 25810233
[TBL] [Abstract][Full Text] [Related]
11. Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer.
Lantis JC; Boone D; Gendics C; Todd G
Adv Skin Wound Care; 2009 Apr; 22(4):167-71. PubMed ID: 19325276
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.
Steed DL
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):143S-149S; discussion 150S-151S. PubMed ID: 16799381
[TBL] [Abstract][Full Text] [Related]
13. A review of the literature on topical therapies for diabetic foot ulcers. Part 2: Advanced treatments.
White R; McIntosh C
J Wound Care; 2009 Aug; 18(8):335-41. PubMed ID: 19862873
[TBL] [Abstract][Full Text] [Related]
14. [Approval for recombinant growth factor. Since January 2000, patients with diabetic foot ulcers can be treated with the growth factor becaplermin (Regranex), manufactured with genetic technology].
Fruhstorfer B
Internist (Berl); 2000 Jan; 41(1):A38. PubMed ID: 10712088
[No Abstract] [Full Text] [Related]
15. Impact of a preventive program on amputation rates in the diabetic population.
King LB
J Wound Ostomy Continence Nurs; 2008; 35(5):479-82; quiz 483-4. PubMed ID: 18794698
[TBL] [Abstract][Full Text] [Related]
16. Preventive care of the diabetic foot.
Fritschi C
Nurs Clin North Am; 2001 Jun; 36(2):303-20, vii. PubMed ID: 11382565
[TBL] [Abstract][Full Text] [Related]
17. The management of diabetic foot disease in Finland.
Seppänen S
J Wound Care; 1999 Sep; 8(8):420-1. PubMed ID: 10808854
[No Abstract] [Full Text] [Related]
18. WHS guidelines update: Diabetic foot ulcer treatment guidelines.
Lavery LA; Davis KE; Berriman SJ; Braun L; Nichols A; Kim PJ; Margolis D; Peters EJ; Attinger C
Wound Repair Regen; 2016; 24(1):112-26. PubMed ID: 26663430
[No Abstract] [Full Text] [Related]
19. Diabetic foot ulcer management: the podiatrist's perspective.
Turns M
Br J Community Nurs; 2013 Dec; Suppl():S14, S16-9. PubMed ID: 24796080
[TBL] [Abstract][Full Text] [Related]
20. Use of Regranex gel for diabetic foot ulcers.
Piascik P
J Am Pharm Assoc (Wash); 1998; 38(5):628-30. PubMed ID: 9782698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
